Exclusive

Publication

Byline

US Patent Issued to JIANGSU KANION PHARMACEUTICAL on May 12 for "Anti-arrhythmic pharmaceutical composition and preparation method therefor" (Chinese Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,902, issued on May 12, was assigned to JIANGSU KANION PHARMACEUTICAL Co. LTD. (Lianyungang, China). "Anti-arrhythmic pharmaceutical composit... Read More


US Patent Issued to SUMMIT BIOSCIENCES on May 12 for "Drug products for intranasal administration and uses thereof" (Kentucky Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,903, issued on May 12, was assigned to SUMMIT BIOSCIENCES INC. (Lexington, Ky.). "Drug products for intranasal administration and uses there... Read More


US Patent Issued to INDIVIOR UK on May 12 for "Buprenorphine dosing regimens" (Virginia Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,904, issued on May 12, was assigned to INDIVIOR UK Ltd. (Hull, Great Britain). "Buprenorphine dosing regimens" was invented by Azmi Nasser (... Read More


US Patent Issued to EISAI R&D MANAGEMENT on May 12 for "Aryl pladienolides for the treatment of neoplastic disorders" (Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,905, issued on May 12, was assigned to EISAI R&D MANAGEMENT Co. LTD. (Tokyo). "Aryl pladienolides for the treatment of neoplastic disorders"... Read More


US Patent Issued to Cambridge Enterprise on May 12 for "Treatment and prognosis of pancreatic cancer" (British Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,906, issued on May 12, was assigned to Cambridge Enterprise Ltd. (Cambridge, Great Britain). "Treatment and prognosis of pancreatic cancer" ... Read More


US Patent Issued to NIRMANA HEALTH on May 12 for "Hair loss therapy" (New York Inventor)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,907, issued on May 12, was assigned to NIRMANA HEALTH INC. (Dover, Del.). "Hair loss therapy" was invented by Animesh Sinha (Amherst, N.Y.).... Read More


US Patent Issued to Incyte, Incyte Holdings on May 12 for "Topical formulation for a JAK inhibitor" (Pennsylvania, Texas Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,908, issued on May 12, was assigned to Incyte Corp. (Wilmington, Del.) and Incyte Holdings Corp. (Wilmington, Del.). "Topical formulation fo... Read More


US Patent Issued to Dana-Farber Cancer Institute on May 12 for "Allosteric EGFR inhibitors and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,909, issued on May 12, was assigned to Dana-Farber Cancer Institute Inc. (Boston). "Allosteric EGFR inhibitors and methods of use thereof" w... Read More


US Patent Issued to Janssen Pharmaceutica on May 12 for "Inhibitors of Bruton's tyrosine kinase and methods of their use" (American, Belgian Inventors)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,910, issued on May 12, was assigned to Janssen Pharmaceutica NV (Beerse, Belgium). "Inhibitors of Bruton's tyrosine kinase and methods of th... Read More


US Patent Issued to CHILDREN'S HOSPITAL MEDICAL CENTER on May 12 for "Methods and compositions for the treatment of pulmonary fibrosis using volasertib" (Ohio Inventor)

ALEXANDRIA, Va., May 12 -- United States Patent no. 12,622,911, issued on May 12, was assigned to CHILDREN'S HOSPITAL MEDICAL CENTER (Cincinnati). "Methods and compositions for the treatment of pulmo... Read More